“Inhalable” Self-Spreading Vaccines that Spread Like a Virus, “Circumvent Compliance Issues”
February 17th, 2024Via: Informed Consent Action Network:
A new class of “encrypted RNA” vaccines are being developed where the RNA would piggyback onto an existing wild virus and spread from person to person without any person’s knowledge or consent. Although this may sound like science fiction, it is far from it. Two companies involved in this research have received millions of dollars from the federal government. A study using this technology on hamsters and the SARS-Cov-2 virus has already been completed and a Phase I trial on humans is in the works. ICAN’s attorneys have already sent legal demands to all government agencies involved.
…
This so-called “therapy” uses a technology called TIPs (Therapeutic Interfering Particles), which are described as “engineered molecular parasites” that piggyback on a wild virus. If you get the virus, you also get these parasites. Once inside an infected person, the TIPs are supposed to rapidly multiply, hijacking the resources the wild virus needs to multiply and therefore stopping the virus.
Supporters of this technology claim it will “solve” several problems with traditional vaccine delivery, including “behavior barriers” like noncompliance. Meaning everyone gets vaccinated—whether they like it or not.
…
The other company working on similar vaccines, VxBiosciences, appears to collaborate with the J. David Gladstone Institutes, led by Dr. Leor Weinberger—who happens to be Ariel’s brother. Patents are already established, such as this one by Leor and Gladstone Institutes in 2017. In a 2020 TEDMED talk, Leor talked about how using viruses would “convert super-spreaders from spreading the virus to spreading the therapy.”
HHS issued a $4.8 million grant to VxBiosciences for “Autonomously Deploying, Co-evolving SARS-CoV-2 Antiviral.” The grant was for engineering “therapeutic molecular parasites of SARS-CoV-2 that can co-adapt and transmit among infected hosts … acting as single-administration therapies that circumvent compliance issues.”
